JPMorgan Chase & Co. Sells 119,024 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

JPMorgan Chase & Co. trimmed its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 10.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,057,167 shares of the company’s stock after selling 119,024 shares during the period. JPMorgan Chase & Co.’s holdings in Recursion Pharmaceuticals were worth $7,146,000 at the end of […]